Donna Kerrigan

3.0k total citations
41 papers, 2.7k citations indexed

About

Donna Kerrigan is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Donna Kerrigan has authored 41 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Organic Chemistry. Recurrent topics in Donna Kerrigan's work include Cancer therapeutics and mechanisms (30 papers), DNA and Nucleic Acid Chemistry (20 papers) and DNA Repair Mechanisms (12 papers). Donna Kerrigan is often cited by papers focused on Cancer therapeutics and mechanisms (30 papers), DNA and Nucleic Acid Chemistry (20 papers) and DNA Repair Mechanisms (12 papers). Donna Kerrigan collaborates with scholars based in United States, Malaysia and United Kingdom. Donna Kerrigan's co-authors include Yves Pommier, Leonard A. Zwelling, Kurt W. Kohn, Joseph M. Covey, Connie Holm, Ronald E. Schwartz, Richard Bertrand, Michael R. Mattern, Stephen Michaels and Judith Markovits and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Donna Kerrigan

41 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna Kerrigan United States	27	2.4k	1.2k	539	429	175	41	2.7k
K M Tewey United States	7	3.3k 1.3×	1.4k 1.2×	752 1.4×	712 1.7×	224 1.3×	7	3.9k
Ryoji Ishida Japan	23	2.0k 0.8×	680 0.6×	373 0.7×	365 0.9×	101 0.6×	49	2.4k
Joseph M. Covey United States	29	2.4k 1.0×	802 0.7×	347 0.6×	320 0.7×	148 0.8×	88	3.0k
Y H Hsiang United States	14	3.9k 1.6×	1.9k 1.6×	1.1k 2.0×	576 1.3×	415 2.4×	15	4.3k
Jan M. Woynarowski United States	24	1.5k 0.6×	1.5k 1.2×	134 0.2×	414 1.0×	106 0.6×	56	2.8k
Mary Jo Caranfa United States	10	1.5k 0.6×	748 0.6×	393 0.7×	446 1.0×	305 1.7×	12	1.9k
Elisabetta Leo United Kingdom	22	2.2k 0.9×	1.1k 0.9×	255 0.5×	362 0.8×	156 0.9×	38	2.8k
Yoji Ikegami Japan	19	1.2k 0.5×	1.2k 1.0×	203 0.4×	146 0.3×	107 0.6×	43	1.9k
Michael I. Walton United Kingdom	28	1.7k 0.7×	719 0.6×	248 0.5×	308 0.7×	57 0.3×	49	2.5k
M.D. Feese United States	15	1.3k 0.5×	379 0.3×	396 0.7×	359 0.8×	124 0.7×	18	1.6k

Countries citing papers authored by Donna Kerrigan

Since Specialization

Citations

This map shows the geographic impact of Donna Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Kerrigan more than expected).

Fields of papers citing papers by Donna Kerrigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Kerrigan. The network helps show where Donna Kerrigan may publish in the future.

Co-authorship network of co-authors of Donna Kerrigan

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Kerrigan. A scholar is included among the top collaborators of Donna Kerrigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Kerrigan. Donna Kerrigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertrand, Richard, Patrick M. O’Connor, Donna Kerrigan, & Yves Pommier. (1992). Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells. European Journal of Cancer. 28(4-5). 743–748. 100 indexed citations

Grabowski, Dale, et al.. (1992). Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone. Biochemical Pharmacology. 44(5). 937–945. 19 indexed citations

Bertrand, Richard, et al.. (1991). Cell death induced by topoisomerase inhibitors. Biochemical Pharmacology. 42(1). 77–85. 72 indexed citations

Pommier, Yves, Thomas M. Rünger, Donna Kerrigan, & Kenneth H. Kraemer. (1991). Relationship of DNA strand breakage produced by bromodeoxyuridine to topoisomerase II activity in Bloom-syndrome fibroblasts. Mutation Research/DNA Repair. 254(2). 185–190. 5 indexed citations

Nieves‐Neira, Wilberto, et al.. (1991). S-Phase Population Analysis Does Not Correlate with the Cytotoxicity of Camptothecin and 10,11-Methylenedioxycamptothecin in Human Colon Carcinoma HT-29 Cells. 3(8). 233–240. 29 indexed citations

Kamath, N., Dale Grabowski, F H Drake, et al.. (1991). Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.. PubMed. 3(2). 37–44. 6 indexed citations

O’Connor, Patrick M., Donna Kerrigan, Richard Bertrand, Kurt W. Kohn, & Yves Pommier. (1990). 10,11-Methylenedioxycamptothecin, a Topoisomerase I Inhibitor of Increased Potency: DNA Damage and Correlation to Cytotoxicity in Human Colon Carcinoma (HT-29) Cells. PubMed. 2(12). 395–400. 17 indexed citations

Sinha, Birandra K., Pedro M. Politi, Helen M. Eliot, Donna Kerrigan, & Yves Pommier. (1990). Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide. European Journal of Cancer and Clinical Oncology. 26(5). 590–593. 24 indexed citations

Pommier, Yves, et al.. (1989). Topological complexes between DNA and topoisomerase II and the effects of polyamines. Biochemistry. 28(3). 995–1002. 52 indexed citations

10.

Holm, Connie, Joseph M. Covey, Donna Kerrigan, & Yves Pommier. (1989). Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.. PubMed. 49(22). 6365–8. 334 indexed citations

11.

Covey, Joseph M., Kurt W. Kohn, Donna Kerrigan, Eugene J. Tilchen, & Yves Pommier. (1988). Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.. PubMed. 48(4). 860–5. 66 indexed citations

12.

Pommier, Yves, et al.. (1988). Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.. PubMed. 48(3). 512–6. 64 indexed citations

13.

Markovits, Judith, Yves Pommier, Donna Kerrigan, et al.. (1987). Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.. PubMed. 47(8). 2050–5. 98 indexed citations

14.

Mattern, Michael R., Donna Kerrigan, & Yves Pommier. (1987). Nucleoid sedimentation analysis of DNA strand breaks induced in cells exposed to DNA intercalating agents. Pharmacology & Therapeutics. 34(2). 303–319. 10 indexed citations

15.

Pommier, Yves, Joseph M. Covey, Donna Kerrigan, et al.. (1987). Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines. Biochemical Pharmacology. 36(20). 3477–3486. 45 indexed citations

16.

Pommier, Yves, et al.. (1987). DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators. Nucleic Acids Research. 15(16). 6713–6731. 121 indexed citations

17.

Pommier, Yves, et al.. (1986). Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.. PubMed. 46(6). 3075–81. 152 indexed citations

18.

Johnston, James B., et al.. (1983). Comparison of dna scission and cytotoxicity produced by adriamycin and 5-iminodaunorubicin in human colon carcinoma cells. Biochemical Pharmacology. 32(14). 2255–2258. 13 indexed citations

19.

Zwelling, Leonard A., Stephen Michaels, Donna Kerrigan, Yves Pommier, & Kurt W. Kohn. (1982). Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium. Biochemical Pharmacology. 31(20). 3261–3267. 78 indexed citations

20.

Poirier, Miriam C., Stephen J. Lippard, Leonard A. Zwelling, et al.. (1982). Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.. Proceedings of the National Academy of Sciences. 79(21). 6443–6447. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact